Literature DB >> 21562927

Enhanced exon 2 skipping caused by c.910G>A variant and alternative splicing of MEFV genes in two independent cases of familial Mediterranean fever.

Yumi Tone1, Tomoko Toma, Akiko Toga, Yasuhisa Sakakibara, Taizo Wada, Masahiro Yabe, Hiromitu Kusafuka, Akihiro Yachie.   

Abstract

Most reported cases of familial Mediterranean fever (FMF) involve missense mutations of MEFV concentrated within exon 10. We experienced two independent pedigrees of a unique variant in the MEFV gene that might cause excessive exon 2 skipping due to enhanced alternative splicing. In this study, we tried to elucidate the molecular mechanism of the MEFV variant as a cause of the FMF phenotype. Peripheral blood was obtained from volunteers and two patients with homozygous c.910G>A variant of the MEFV gene. MEFV messenger RNA (mRNA) expression patterns in mononuclear cells and granulocytes were compared using forward and reverse primers from exons 1 and 3, respectively. Expression profiles of pyrin were examined by transfecting wild-type and variant MEFV genes into HEK293T cells. Expression of normal-sized mRNA was extremely reduced in these patients, whereas that of aberrant short mRNA, deleting exon 2 (Δex2), was significantly increased. Immunohistochemical and immunoblotting analyses revealed a truncated immunoreactive pyrin protein in cells transfected with Δex2 cDNA. The MEFV gene c.910G>A variant results in accelerated aberrant splicing with abnormal protein size, presumably leading to anomalous pyrin function. This is the first report to show that an MEFV variant other than missense mutation is responsible for the FMF phenotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21562927     DOI: 10.1007/s10165-011-0461-4

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  2 in total

1.  CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.

Authors:  Junichi Watanabe; Ken Sato; Yukiko Osawa; Toshikatsu Horiuchi; Shoichiro Kato; Reina Hikota-Saga; Takaaki Maekawa; Takeshi Yamamura; Ayako Kobayashi; Shinichi Kobayashi; Fumihiko Kimura
Journal:  Int J Hematol       Date:  2018-03-29       Impact factor: 2.490

2.  Alternatively spliced MEFV transcript lacking exon 2 and its protein isoform pyrin-2d implies an epigenetic regulation of the gene in inflammatory cell culture models.

Authors:  Gokce Celikyapi Erdem; Sule Erdemir; Irem Abaci; Asli K Kirectepe Aydin; Elif Everest; Eda Tahir Turanli
Journal:  Genet Mol Biol       Date:  2017-08-31       Impact factor: 1.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.